Related Experiment Video
Updated: Nov 3, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Computational Models Used to Predict Cardiovascular Complications in Chronic Kidney Disease Patients: A Systematic
Alexandru Burlacu1,2,3, Adrian Iftene4, Iolanda Valentina Popa2
1Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Iasi, Romania.
Insights
Computational methods show promise for predicting cardiovascular complications in chronic kidney disease (CKD) patients. Further rigorous validation is needed to integrate these artificial intelligence and regression models into clinical practice for improved cardiovascular risk prediction.
Area of Science:
- Nephrology
- Cardiology
- Medical Informatics
Background:
- Cardiovascular complications (CVC) are the primary cause of mortality in chronic kidney disease (CKD) patients.
- Existing cardiovascular disease risk prediction models are not validated for the CKD population.
- There is a need for reliable predictive tools tailored to CKD patients.
Purpose of the Study:
- To systematically review the literature on computational methods for predicting CVC in CKD patients.
- To assess the outcomes of artificial intelligence (AI) and regression-based models in this context.
- To identify trends and gaps in current research.
Main Methods:
- Systematic literature search of MEDLINE/PubMed, EMBASE, and ScienceDirect.
- Assessment of study risk of bias and reporting quality using TRIPOD and PROBAST tools.
- Inclusion of 16 relevant studies, including 15 non-randomized studies and 1 ongoing trial.
Main Results:
- Twelve studies utilized AI or regression models for CVC prediction in CKD.
- Four studies focused on other cardiovascular-related predictions in CKD.
- The identified studies demonstrate promising current performance but highlight a need for more rigorous methodologies.
Conclusions:
- Computational methods show potential for cardiovascular risk prediction in CKD.
- Further prospective, randomized clinical trials and external validations are essential.
- These advanced computational solutions may bridge the gap in predictive tools for CKD patients.
Abstract:
Background and objectives: cardiovascular complications (CVC) are the leading cause of death in patients with chronic kidney disease (CKD). Standard cardiovascular disease risk prediction models used in the general population are not validated in patients with CKD. We aim to systematically review the up-to-date literature on reported outcomes of computational methods such as artificial intelligence (AI) or regression-based models to predict CVC in CKD patients. Materials and methods: the electronic databases of MEDLINE/PubMed, EMBASE, and ScienceDirect were systematically searched. The risk of bias and reporting quality for each study were assessed against transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) and the prediction model risk of bias assessment tool (PROBAST). Results: sixteen papers were included in the present systematic review: 15 non-randomized studies and 1 ongoing clinical trial. Twelve studies were found to perform AI or regression-based predictions of CVC in CKD, either through single or composite endpoints. Four studies have come up with computational solutions for other CV-related predictions in the CKD population. Conclusions: the identified studies represent palpable trends in areas of clinical promise with an encouraging present-day performance. However, there is a clear need for more extensive application of rigorous methodologies. Following the future prospective, randomized clinical trials, and thorough external validations, computational solutions will fill the gap in cardiovascular predictive tools for chronic kidney disease.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Diuretics

